Ftse Mib
34.888,79
0,09%
DAX
20.405,92
-0,11%
S&P 500
6.051,09
0,00%
NASDAQ
19.926,72
0,12%
Bitcoin
101.047,73
-0,40%
Pepperstone
Advertisement
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Lumos Pharma Inc (LUMO) Lumos Pharma Inc (LUMO) Notizie

Lumos Pharma Inc

LUMO
4,34
0,00 (0,00%)
13 Dic 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
14/12/202403:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/12/202403:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/12/202403:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/12/202403:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/12/202403:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/12/202403:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/12/202403:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/12/202403:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/12/202403:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/12/202403:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/12/202403:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/12/202403:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/12/202414:10EDGAR2Form AW - Amendment Withdrawal Request
13/12/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
12/12/202417:05EDGAR2Form POS AM - Post-Effective amendments for registration..
12/12/202416:51EDGAR2Form S-8 POS - Securities to be offered to employees in..
12/12/202416:28EDGAR2Form 8-K - Current report
12/12/202415:42EDGAR2Form SC 14D9/A - Solicitation, recommendation statements:..
12/12/202415:42EDGAR2Form 25-NSE - Notification filed by national security..
12/12/202414:57EDGAR2Form SC TO-T/A - Tender offer statement by Third Party:..
12/12/202414:47GLOBELumos Pharma and Double Point Ventures Announce Successful..
29/11/202423:09EDGAR2Form SC 14D9/A - Solicitation, recommendation statements:..
29/11/202423:01EDGAR2Form SC TO-T/A - Tender offer statement by Third Party:..
25/11/202412:02EDGAR2Form 8-K - Current report
21/11/202415:00GLOBEUpdated Phase 2 OraGrowtH Data Presented at ESPE 2024..
14/11/202415:04EDGAR2Form SC 14D9 - Solicitation, recommendation statements
14/11/202414:22EDGAR2Form SC TO-T - Tender offer statement by Third Party
13/11/202400:27EDGAR2Form SC 13G - Statement of Beneficial Ownership by Certain..
07/11/202421:12EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
30/10/202421:05GLOBELumos Pharma Announces Two Abstracts Accepted for Oral..
23/10/202421:51PRNUSALERT: Rowley Law PLLC is Investigating Proposed Acquisition..
23/10/202414:24EDGAR2Form SC14D9C - Written communication relating to third party..
23/10/202414:10EDGAR2Form 8-K - Current report
23/10/202414:00GLOBELumos Pharma Enters into Definitive Merger Agreement with..
25/9/202422:05GLOBELumos Pharma Announces Abstract Accepted for Oral..
05/9/202415:00GLOBELumos Pharma Announces Abstract Accepted for Presentation at..
15/8/202415:00GLOBELumos Pharma to Participate in H.C. Wainwright 26th Annual..
06/8/202423:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/8/202423:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/8/202423:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/8/202414:18EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
01/8/202423:07EDGAR2Form 8-K - Current report
01/8/202422:05GLOBELumos Pharma Reports Second Quarter 2024 Financial..
23/7/202422:05GLOBELumos Pharma to Report Second Quarter 2024 Financial Results..
07/6/202422:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/6/202422:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/6/202422:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/6/202422:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/6/202422:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/6/202422:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
Apertura: Min: Max:
Chiusura: 4,34

La tua Cronologia

NASDAQ
LUMO
Lumos Pharma
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network